Background Lack of specific definitions of clinical characteristics, disease severity, and risk
and preventive factors of post-COVID-19 syndrome (PCS) severely impacts research and …

Objective: To compare the two phases of long COVID, namely ongoing symptomatic COVID-
19 (OSC; signs and symptoms from 4 to 12 weeks from initial infection) and post-COVID-19 …

There is an established literature on the symptoms and complications of COVID‐19 but the
after‐effects of COVID‐19 are not well understood with few studies reporting persistent …

Background Post-acute sequelae of COVID-19 (PASC) includes a heterogeneous group of
patients with variable symptomatology, who may respond to different therapeutic …

Introduction Post‐COVID‐19 syndrome affects approximately 10–25% of people after a
COVID‐19 infection, irrespective of initial COVID‐19 severity. The aim of this project was to …

Long COVID is a chronic condition characterized by symptoms such as fatigue, dyspnea,
and cognitive impairment that persist or relapse months after an acute infection with the …

Background “Long COVID” is characterized by a variety of symptoms and an important
burden for affected people. Our objective was to describe long COVID symptomatology …

An estimated 10–15% of those infected with SARS-CoV-2 may have post-COVID-19
condition. Common lingering signs and symptoms include shortness of breath, fatigue, high …

Whilst the entire world is battling the second wave of COVID-19, a substantial proportion of
patients who have suffered from the condition in the past months are reporting symptoms …

Background Long COVID is a well recognised, if heterogeneous, entity. Acute respiratory
infections (ARIs) due to other pathogens may cause long-term symptoms, but few studies …